CD146 protein in prostate cancer: Revisited with two different antibodies

Pathology

Volumn 40, Issue 5, 2008, Pages 457-464

  Fritzsche, Florian Rudolf ^a   Wassermann, Kirsten ^a   Rabien, Anja ^a   Schicktanz, Hanka ^a   Dankof, Anja ^a   Loening, Stefan A ^a   Dietel, Manfred ^a   Jung, Klaus ^a   Kristiansen, Glen ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antibody; CD146; Immunoglobulin; Immunohistochemistry; MUC18; Prostate cancer

Indexed keywords

CD146 ANTIGEN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 46749105273     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802197996     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
2. Kristiansen G, Yu Y, Schluns K, et al. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol 2003; 25: 77-81.
3. Luca M, Hunt B, Bucana CD, et al. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 1993; 3: 35-41.
4. Pires FR, Shih I, Cruz Perez DE, et al. Mel-CAM (CD146) expression in parotid mucoepidermoid carcinoma. Oral Oncol 2003; 39: 277-81.
5. Shih IM, Wang TL, Westra WH. Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res 1996; 2: 569-75.
6. Wu GJ, Wu MW, Wang SW, et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Gene 2001; 279: 17-31.
7. Wu GJ, Fu P, Chiang CF, et al. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urol 2005; 173: 1778-83.
8. Chiang CF, Son EL, Wu GJ. Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Prostate 2005; 64: 408-18.
9. Shih IM. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999; 189: 4-11.
10. Furstenberger G, von Moos R, Senn HJ, et al. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis. Br J Cancer 2005; 93: 793-8.
11. Zigrino P, Mauch C, Fox JW, et al. Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 2005; 116: 853-9.
12. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
13. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
14. Shih IM, Nesbit M, Herlyn M, et al. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol 1998; 11: 1098-106.
15. Omara-Opyene AL, Qiu J, Shah GV, et al. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest 2004; 84: 894-907.
16. Aldovini D, Demichelis F, Doglioni C, et al. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer 2006; 119: 1920-6.
17. Kang Y, Wang F, Feng J, et al. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res 2006; 16: 313-8.
18. Wu GJ, Peng Q, Fu P, et al. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene 2004; 327: 201-13.
19. Yang H, Wang S, Liu Z, et al. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability. Gene 2001; 265: 133-45.
20. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999; 18: 345-57.
21. Pardo M, Garcia A, Thomas B, et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 2006; 119: 1014-22.
22. Shih LM, Hsu MY, Palazzo JP, et al. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol 1997; 151: 745-51.
23. Garcia S, Dales JP, Charafe-Jauffret E, et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol 2007; 38: 830-41.